Acorda Therapeutics Inc Net debt/EBITDA
Quel est le Net debt/EBITDA de Acorda Therapeutics Inc?
Le Net debt/EBITDA de Acorda Therapeutics Inc est 80.97
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur NASDAQ par rapport à Acorda Therapeutics Inc
Que fait Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Entreprises avec net debt/ebitda similaire à Acorda Therapeutics Inc
- Associated Capital Inc a Net debt/EBITDA de 80.49
- Centric Health a Net debt/EBITDA de 80.63
- Compagnie Immobilière de Belgique SA a Net debt/EBITDA de 80.63
- Town Sports International a Net debt/EBITDA de 80.64
- Jiu Rong a Net debt/EBITDA de 80.76
- Acheter-Louer.Fr SA a Net debt/EBITDA de 80.96
- Acorda Therapeutics Inc a Net debt/EBITDA de 80.97
- Citigroup Inc a Net debt/EBITDA de 80.98
- Crown a Net debt/EBITDA de 81.22
- Companhia Siderurgica Nacional a Net debt/EBITDA de 81.31
- New Residential Investment Corp a Net debt/EBITDA de 81.63
- Bassett Furniture Industries a Net debt/EBITDA de 81.64
- Carmax Inc a Net debt/EBITDA de 81.72